

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.09038368 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.09038368 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.79269915 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.79269915 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.41077893 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.04537993 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 5.87329246 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.83181080 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.83181080 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.83181080 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.74648088 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.73341250 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.50355544 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.48777154 |
| 15 | urea metabolic process (GO:0019627) | 5.38217733 |
| 16 | urea cycle (GO:0000050) | 5.38217733 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 5.33088234 |
| 18 | cysteine metabolic process (GO:0006534) | 5.26618941 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.21635946 |
| 20 | complement activation, alternative pathway (GO:0006957) | 5.20902676 |
| 21 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.19159468 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 5.12061729 |
| 23 | regulation of protein activation cascade (GO:2000257) | 5.06474087 |
| 24 | protein carboxylation (GO:0018214) | 4.92864793 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.92864793 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 4.92508796 |
| 27 | bile acid metabolic process (GO:0008206) | 4.88172389 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 4.87857330 |
| 29 | regulation of fibrinolysis (GO:0051917) | 4.87401038 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 4.86372276 |
| 31 | homocysteine metabolic process (GO:0050667) | 4.81218298 |
| 32 | lysine catabolic process (GO:0006554) | 4.80336710 |
| 33 | lysine metabolic process (GO:0006553) | 4.80336710 |
| 34 | regulation of complement activation (GO:0030449) | 4.76029981 |
| 35 | amino-acid betaine metabolic process (GO:0006577) | 4.69760510 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.65386574 |
| 37 | reverse cholesterol transport (GO:0043691) | 4.64723820 |
| 38 | cellular ketone body metabolic process (GO:0046950) | 4.55178042 |
| 39 | alpha-amino acid catabolic process (GO:1901606) | 4.51408323 |
| 40 | tyrosine metabolic process (GO:0006570) | 4.50263695 |
| 41 | triglyceride homeostasis (GO:0070328) | 4.50041997 |
| 42 | acylglycerol homeostasis (GO:0055090) | 4.50041997 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.48546681 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.48546681 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.48546681 |
| 46 | exogenous drug catabolic process (GO:0042738) | 4.47016171 |
| 47 | regulation of cholesterol esterification (GO:0010872) | 4.46756548 |
| 48 | coenzyme catabolic process (GO:0009109) | 4.31703219 |
| 49 | phospholipid efflux (GO:0033700) | 4.26502712 |
| 50 | ethanol oxidation (GO:0006069) | 4.23882952 |
| 51 | cellular amino acid catabolic process (GO:0009063) | 4.21245386 |
| 52 | plasma lipoprotein particle clearance (GO:0034381) | 4.20667251 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 4.20553103 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.20553103 |
| 55 | bile acid and bile salt transport (GO:0015721) | 4.18227087 |
| 56 | indolalkylamine metabolic process (GO:0006586) | 4.12280280 |
| 57 | omega-hydroxylase P450 pathway (GO:0097267) | 4.10574123 |
| 58 | positive regulation of glycolytic process (GO:0045821) | 4.08863252 |
| 59 | glycine metabolic process (GO:0006544) | 4.07314674 |
| 60 | glutamate metabolic process (GO:0006536) | 4.04415374 |
| 61 | acetyl-CoA metabolic process (GO:0006084) | 4.00502801 |
| 62 | cellular biogenic amine catabolic process (GO:0042402) | 3.98143196 |
| 63 | amine catabolic process (GO:0009310) | 3.98143196 |
| 64 | cellular glucuronidation (GO:0052695) | 3.97354615 |
| 65 | serine family amino acid metabolic process (GO:0009069) | 3.96418948 |
| 66 | cholesterol efflux (GO:0033344) | 3.94846779 |
| 67 | short-chain fatty acid metabolic process (GO:0046459) | 3.94228097 |
| 68 | ketone body metabolic process (GO:1902224) | 3.93431008 |
| 69 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.93165697 |
| 70 | benzene-containing compound metabolic process (GO:0042537) | 3.92409606 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 3.92032825 |
| 72 | imidazole-containing compound metabolic process (GO:0052803) | 3.92005283 |
| 73 | fatty acid beta-oxidation (GO:0006635) | 3.88175771 |
| 74 | 2-oxoglutarate metabolic process (GO:0006103) | 3.86495750 |
| 75 | epoxygenase P450 pathway (GO:0019373) | 3.84841188 |
| 76 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.82957590 |
| 77 | positive regulation of lipid catabolic process (GO:0050996) | 3.82948515 |
| 78 | fatty acid oxidation (GO:0019395) | 3.82469692 |
| 79 | organic acid catabolic process (GO:0016054) | 3.81543336 |
| 80 | carboxylic acid catabolic process (GO:0046395) | 3.81543336 |
| 81 | phospholipid homeostasis (GO:0055091) | 3.80651348 |
| 82 | arginine metabolic process (GO:0006525) | 3.80017323 |
| 83 | plasma lipoprotein particle assembly (GO:0034377) | 3.78780954 |
| 84 | valine metabolic process (GO:0006573) | 3.77162303 |
| 85 | serine family amino acid biosynthetic process (GO:0009070) | 3.75423187 |
| 86 | lipid oxidation (GO:0034440) | 3.75172267 |
| 87 | monocarboxylic acid catabolic process (GO:0072329) | 3.73464110 |
| 88 | fatty acid catabolic process (GO:0009062) | 3.71652120 |
| 89 | low-density lipoprotein particle remodeling (GO:0034374) | 3.71567310 |
| 90 | regulation of cholesterol homeostasis (GO:2000188) | 3.68192422 |
| 91 | negative regulation of protein activation cascade (GO:2000258) | 3.66367509 |
| 92 | drug catabolic process (GO:0042737) | 3.65629451 |
| 93 | cytolysis (GO:0019835) | 3.65398071 |
| 94 | carnitine metabolic process (GO:0009437) | 3.62557057 |
| 95 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.60181621 |
| 96 | cofactor catabolic process (GO:0051187) | 3.58564420 |
| 97 | aspartate family amino acid catabolic process (GO:0009068) | 3.58441290 |
| 98 | complement activation, classical pathway (GO:0006958) | 3.57788853 |
| 99 | complement activation (GO:0006956) | 3.56866294 |
| 100 | negative regulation of lipase activity (GO:0060192) | 3.55427043 |
| 101 | fibrinolysis (GO:0042730) | 3.54699789 |
| 102 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.53464606 |
| 103 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.53464606 |
| 104 | cholesterol homeostasis (GO:0042632) | 3.52739045 |
| 105 | regulation of bile acid biosynthetic process (GO:0070857) | 3.52431921 |
| 106 | negative regulation of complement activation (GO:0045916) | 3.43446783 |
| 107 | oxidative demethylation (GO:0070989) | 3.40262169 |
| 108 | phenylpropanoid metabolic process (GO:0009698) | 3.23328329 |
| 109 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.14242220 |
| 110 | regulation of energy homeostasis (GO:2000505) | 3.09423457 |
| 111 | flavonoid metabolic process (GO:0009812) | 3.04722548 |
| 112 | regulation of protein glycosylation (GO:0060049) | 3.00392313 |
| 113 | biotin metabolic process (GO:0006768) | 2.94303948 |
| 114 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.89333671 |
| 115 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.89333671 |
| 116 | drug metabolic process (GO:0017144) | 2.87167058 |
| 117 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.84397826 |
| 118 | cellular response to ethanol (GO:0071361) | 2.84204965 |
| 119 | macroautophagy (GO:0016236) | 2.83148548 |
| 120 | branched-chain amino acid catabolic process (GO:0009083) | 2.73589626 |
| 121 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.72010600 |
| 122 | S-adenosylmethionine metabolic process (GO:0046500) | 2.67203152 |
| 123 | uronic acid metabolic process (GO:0006063) | 2.64937046 |
| 124 | glucuronate metabolic process (GO:0019585) | 2.64937046 |
| 125 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.57728114 |
| 126 | retinal metabolic process (GO:0042574) | 2.57068503 |
| 127 | inositol phosphate catabolic process (GO:0071545) | 2.56948406 |
| 128 | xenobiotic catabolic process (GO:0042178) | 2.56594827 |
| 129 | regulation of glycolytic process (GO:0006110) | 2.55925401 |
| 130 | regulation of glucokinase activity (GO:0033131) | 2.54937495 |
| 131 | regulation of hexokinase activity (GO:1903299) | 2.54937495 |
| 132 | Golgi to endosome transport (GO:0006895) | 2.50580834 |
| 133 | establishment of protein localization to Golgi (GO:0072600) | 2.48019695 |
| 134 | positive regulation of fatty acid oxidation (GO:0046321) | 2.47711738 |
| 135 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.46531161 |
| 136 | negative regulation of neurological system process (GO:0031645) | 2.45691514 |
| 137 | fatty acid transmembrane transport (GO:1902001) | 2.41294784 |
| 138 | fatty acid homeostasis (GO:0055089) | 2.41269583 |
| 139 | negative regulation of humoral immune response (GO:0002921) | 2.40332299 |
| 140 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.40241817 |
| 141 | vascular smooth muscle contraction (GO:0014829) | 2.39761565 |
| 142 | ethanol metabolic process (GO:0006067) | 2.38115808 |
| 143 | carnitine transport (GO:0015879) | 2.36598797 |
| 144 | amino-acid betaine transport (GO:0015838) | 2.36598797 |
| 145 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.34639500 |
| 146 | negative regulation of hormone metabolic process (GO:0032351) | 2.34580731 |
| 147 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.33190171 |
| 148 | melanin biosynthetic process (GO:0042438) | 2.33166108 |
| 149 | branched-chain amino acid metabolic process (GO:0009081) | 2.32044082 |
| 150 | polyol catabolic process (GO:0046174) | 2.31385430 |
| 151 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.30077328 |
| 152 | protein localization to Golgi apparatus (GO:0034067) | 2.29077736 |
| 153 | reflex (GO:0060004) | 2.27824396 |
| 154 | estrogen metabolic process (GO:0008210) | 2.27142801 |
| 155 | COPII vesicle coating (GO:0048208) | 2.25758859 |
| 156 | regulation of lipoprotein metabolic process (GO:0050746) | 2.25694667 |
| 157 | dentate gyrus development (GO:0021542) | 2.25322349 |
| 158 | nitric oxide mediated signal transduction (GO:0007263) | 2.23149545 |
| 159 | secondary metabolite biosynthetic process (GO:0044550) | 2.23133556 |
| 160 | quaternary ammonium group transport (GO:0015697) | 2.22907511 |
| 161 | melanin metabolic process (GO:0006582) | 2.22365166 |
| 162 | glial cell proliferation (GO:0014009) | 2.22280701 |
| 163 | protein targeting to Golgi (GO:0000042) | 2.22050869 |
| 164 | endocrine pancreas development (GO:0031018) | 2.21837123 |
| 165 | keratinocyte development (GO:0003334) | 2.21045401 |
| 166 | brain morphogenesis (GO:0048854) | 2.18566126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.04595017 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.93948497 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.53627519 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.27290850 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.86611887 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.06089893 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.77278134 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.98101652 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.78535424 |
| 10 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.20837455 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.12964300 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.73540657 |
| 13 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.66165451 |
| 14 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.63455270 |
| 15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.60629609 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.53377426 |
| 17 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.42507388 |
| 18 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.33436613 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.11415951 |
| 20 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.08980631 |
| 21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08177033 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.04306391 |
| 23 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.01935498 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.01402556 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.3525146 |
| 26 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.91962012 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.90494324 |
| 28 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.90242347 |
| 29 | FUS_26573619_Chip-Seq_HEK293_Human | 1.86863360 |
| 30 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.81189390 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.79134658 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75334548 |
| 33 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.75093483 |
| 34 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.74120233 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.71178676 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.69474198 |
| 37 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68495866 |
| 38 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.68452155 |
| 39 | TCF4_23295773_ChIP-Seq_U87_Human | 1.63313704 |
| 40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63035676 |
| 41 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.56868068 |
| 42 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.56034856 |
| 43 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.53896292 |
| 44 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.53237864 |
| 45 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.50148493 |
| 46 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.49177466 |
| 47 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.48806273 |
| 48 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.44953307 |
| 49 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.44793262 |
| 50 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.44793262 |
| 51 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.44593003 |
| 52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.43523572 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.41759233 |
| 54 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40806662 |
| 55 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.40204608 |
| 56 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.39471862 |
| 57 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.39321466 |
| 58 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38997131 |
| 59 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38408331 |
| 60 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.38365310 |
| 61 | TP53_16413492_ChIP-PET_HCT116_Human | 1.36029728 |
| 62 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34269891 |
| 63 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.32854280 |
| 64 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.32804926 |
| 65 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.32282061 |
| 66 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.30692204 |
| 67 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.29490881 |
| 68 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.27833237 |
| 69 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.25182300 |
| 70 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.24191896 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24170612 |
| 72 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.24033114 |
| 73 | VDR_22108803_ChIP-Seq_LS180_Human | 1.23656502 |
| 74 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.23614206 |
| 75 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.20054269 |
| 76 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.19973692 |
| 77 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.18798764 |
| 78 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.18701972 |
| 79 | EWS_26573619_Chip-Seq_HEK293_Human | 1.18623700 |
| 80 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18271100 |
| 81 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.17727283 |
| 82 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.17364838 |
| 83 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16041048 |
| 84 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.15715931 |
| 85 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.14721695 |
| 86 | CJUN_26792858_Chip-Seq_BT549_Human | 1.13176310 |
| 87 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.12730058 |
| 88 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11659062 |
| 89 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11466813 |
| 90 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.09832433 |
| 91 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.09247533 |
| 92 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.09211728 |
| 93 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.08623335 |
| 94 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07768166 |
| 95 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.07424687 |
| 96 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06605509 |
| 97 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.05631379 |
| 98 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.04942157 |
| 99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04343270 |
| 100 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.03835191 |
| 101 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02766707 |
| 102 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.02540765 |
| 103 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.02527611 |
| 104 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.01791400 |
| 105 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.01398508 |
| 106 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.99776586 |
| 107 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.99406841 |
| 108 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.98833614 |
| 109 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95822258 |
| 110 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.95016225 |
| 111 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94905693 |
| 112 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.93692482 |
| 113 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.89085430 |
| 114 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85310309 |
| 115 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.84046839 |
| 116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80540370 |
| 117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80276946 |
| 118 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79148620 |
| 119 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77672219 |
| 120 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77243936 |
| 121 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76602060 |
| 122 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76377921 |
| 123 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74544783 |
| 124 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.73798800 |
| 125 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.73798800 |
| 126 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70441994 |
| 127 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.69774311 |
| 128 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.67997302 |
| 129 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.67363982 |
| 130 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.63885424 |
| 131 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.63750414 |
| 132 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.61524655 |
| 133 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60183285 |
| 134 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59173073 |
| 135 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59011177 |
| 136 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56096075 |
| 137 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55438240 |
| 138 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.55238686 |
| 139 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55058456 |
| 140 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.54904013 |
| 141 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.52811277 |
| 142 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51922091 |
| 143 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.51918353 |
| 144 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.51373071 |
| 145 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.50965958 |
| 146 | GATA2_19941826_ChIP-Seq_K562_Human | 0.50281513 |
| 147 | GATA1_19941826_ChIP-Seq_K562_Human | 0.50194595 |
| 148 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.49904046 |
| 149 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49896649 |
| 150 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.49603624 |
| 151 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.49500467 |
| 152 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48949628 |
| 153 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.48729534 |
| 154 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.47938146 |
| 155 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46890035 |
| 156 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.45392094 |
| 157 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.44703287 |
| 158 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.44296763 |
| 159 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44206830 |
| 160 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.43689869 |
| 161 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.42927145 |
| 162 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.42784523 |
| 163 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.42356187 |
| 164 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.42232134 |
| 165 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41509187 |
| 166 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41357962 |
| 167 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.40635774 |
| 168 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.40635774 |
| 169 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.40370532 |
| 170 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.40253759 |
| 171 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.39576370 |
| 172 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.39486532 |
| 173 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.38889635 |
| 174 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.38648127 |
| 175 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.38461636 |
| 176 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.38265379 |
| 177 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.38242696 |
| 178 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.38162106 |
| 179 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.37954627 |
| 180 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.36793503 |
| 181 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36442726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.02833585 |
| 2 | MP0005360_urolithiasis | 7.18807176 |
| 3 | MP0005365_abnormal_bile_salt | 6.19526951 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 6.13333839 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.93138405 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.06952929 |
| 7 | MP0003252_abnormal_bile_duct | 3.82992531 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.70886206 |
| 9 | MP0000372_irregular_coat_pigmentation | 3.35382549 |
| 10 | MP0009840_abnormal_foam_cell | 3.13612215 |
| 11 | MP0009780_abnormal_chondrocyte_physiolo | 3.09251009 |
| 12 | MP0005083_abnormal_biliary_tract | 2.84834381 |
| 13 | MP0005332_abnormal_amino_acid | 2.77435297 |
| 14 | MP0005171_absent_coat_pigmentation | 2.74208157 |
| 15 | MP0000569_abnormal_digit_pigmentation | 2.67587452 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.58963300 |
| 17 | MP0003195_calcinosis | 2.56673684 |
| 18 | MP0003646_muscle_fatigue | 2.41909985 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.36818845 |
| 20 | MP0005075_abnormal_melanosome_morpholog | 2.28768955 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.22205373 |
| 22 | MP0000609_abnormal_liver_physiology | 2.20994979 |
| 23 | MP0002909_abnormal_adrenal_gland | 2.05972117 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 2.05103309 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.87039620 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.85361401 |
| 27 | MP0003868_abnormal_feces_composition | 1.84704936 |
| 28 | MP0000427_abnormal_hair_cycle | 1.79558740 |
| 29 | MP0001764_abnormal_homeostasis | 1.70449766 |
| 30 | MP0005670_abnormal_white_adipose | 1.69636950 |
| 31 | MP0000015_abnormal_ear_pigmentation | 1.68489973 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.65304093 |
| 33 | MP0000371_diluted_coat_color | 1.63466867 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.62183298 |
| 35 | MP0005187_abnormal_penis_morphology | 1.60391798 |
| 36 | MP0009697_abnormal_copulation | 1.58839162 |
| 37 | MP0008775_abnormal_heart_ventricle | 1.57308796 |
| 38 | MP0000013_abnormal_adipose_tissue | 1.57263438 |
| 39 | MP0010386_abnormal_urinary_bladder | 1.57171728 |
| 40 | MP0005551_abnormal_eye_electrophysiolog | 1.54555213 |
| 41 | MP0005174_abnormal_tail_pigmentation | 1.50461268 |
| 42 | MP0001984_abnormal_olfaction | 1.44002614 |
| 43 | MP0004130_abnormal_muscle_cell | 1.42125090 |
| 44 | MP0003186_abnormal_redox_activity | 1.37908879 |
| 45 | MP0002102_abnormal_ear_morphology | 1.36871569 |
| 46 | MP0003011_delayed_dark_adaptation | 1.35813969 |
| 47 | MP0005253_abnormal_eye_physiology | 1.33829166 |
| 48 | MP0005248_abnormal_Harderian_gland | 1.33431481 |
| 49 | MP0009643_abnormal_urine_homeostasis | 1.32857285 |
| 50 | MP0005451_abnormal_body_composition | 1.30820546 |
| 51 | MP0010678_abnormal_skin_adnexa | 1.23738076 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.23686560 |
| 53 | MP0002938_white_spotting | 1.23304436 |
| 54 | MP0002638_abnormal_pupillary_reflex | 1.22193755 |
| 55 | MP0009046_muscle_twitch | 1.21212589 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.19635512 |
| 57 | MP0004381_abnormal_hair_follicle | 1.17338734 |
| 58 | MP0000598_abnormal_liver_morphology | 1.16743032 |
| 59 | MP0005379_endocrine/exocrine_gland_phen | 1.16364118 |
| 60 | MP0000538_abnormal_urinary_bladder | 1.13268645 |
| 61 | MP0001501_abnormal_sleep_pattern | 1.12517976 |
| 62 | MP0005647_abnormal_sex_gland | 1.11924871 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.10118340 |
| 64 | MP0003045_fibrosis | 1.09911614 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 1.09759205 |
| 66 | MP0002095_abnormal_skin_pigmentation | 1.07731859 |
| 67 | MP0002876_abnormal_thyroid_physiology | 1.06811943 |
| 68 | MP0002075_abnormal_coat/hair_pigmentati | 1.06357031 |
| 69 | MP0001986_abnormal_taste_sensitivity | 1.05025766 |
| 70 | MP0000604_amyloidosis | 1.04998016 |
| 71 | MP0009764_decreased_sensitivity_to | 1.04926821 |
| 72 | MP0000516_abnormal_urinary_system | 1.04625638 |
| 73 | MP0005367_renal/urinary_system_phenotyp | 1.04625638 |
| 74 | MP0004924_abnormal_behavior | 1.04077800 |
| 75 | MP0005386_behavior/neurological_phenoty | 1.04077800 |
| 76 | MP0004134_abnormal_chest_morphology | 1.03052450 |
| 77 | MP0001324_abnormal_eye_pigmentation | 1.01785100 |
| 78 | MP0002254_reproductive_system_inflammat | 1.00973909 |
| 79 | MP0002837_dystrophic_cardiac_calcinosis | 0.99423949 |
| 80 | MP0002078_abnormal_glucose_homeostasis | 0.96684823 |
| 81 | MP0002971_abnormal_brown_adipose | 0.96551986 |
| 82 | MP0009763_increased_sensitivity_to | 0.96540148 |
| 83 | MP0000383_abnormal_hair_follicle | 0.96191120 |
| 84 | MP0005636_abnormal_mineral_homeostasis | 0.95234631 |
| 85 | MP0001661_extended_life_span | 0.95189304 |
| 86 | MP0010368_abnormal_lymphatic_system | 0.94853115 |
| 87 | MP0006072_abnormal_retinal_apoptosis | 0.94782415 |
| 88 | MP0000613_abnormal_salivary_gland | 0.94026799 |
| 89 | MP0005334_abnormal_fat_pad | 0.91056128 |
| 90 | MP0005535_abnormal_body_temperature | 0.90883639 |
| 91 | MP0005666_abnormal_adipose_tissue | 0.90193819 |
| 92 | MP0004885_abnormal_endolymph | 0.90154153 |
| 93 | MP0003136_yellow_coat_color | 0.89158572 |
| 94 | MP0001270_distended_abdomen | 0.88918352 |
| 95 | MP0009642_abnormal_blood_homeostasis | 0.88802715 |
| 96 | MP0005084_abnormal_gallbladder_morpholo | 0.87742220 |
| 97 | MP0005645_abnormal_hypothalamus_physiol | 0.86929770 |
| 98 | MP0003950_abnormal_plasma_membrane | 0.86577681 |
| 99 | MP0003633_abnormal_nervous_system | 0.85020783 |
| 100 | MP0008469_abnormal_protein_level | 0.84940285 |
| 101 | MP0003787_abnormal_imprinting | 0.84712760 |
| 102 | MP0002009_preneoplasia | 0.82827931 |
| 103 | MP0005376_homeostasis/metabolism_phenot | 0.81219849 |
| 104 | MP0003122_maternal_imprinting | 0.80373869 |
| 105 | MP0004270_analgesia | 0.78786908 |
| 106 | MP0004484_altered_response_of | 0.75896238 |
| 107 | MP0001186_pigmentation_phenotype | 0.75034465 |
| 108 | MP0004085_abnormal_heartbeat | 0.74165822 |
| 109 | MP0005448_abnormal_energy_balance | 0.74001033 |
| 110 | MP0002557_abnormal_social/conspecific_i | 0.73809702 |
| 111 | MP0005266_abnormal_metabolism | 0.73337243 |
| 112 | MP0002160_abnormal_reproductive_system | 0.73210425 |
| 113 | MP0010352_gastrointestinal_tract_polyps | 0.72575125 |
| 114 | MP0004036_abnormal_muscle_relaxation | 0.72416448 |
| 115 | MP0001756_abnormal_urination | 0.72019149 |
| 116 | MP0002234_abnormal_pharynx_morphology | 0.71876448 |
| 117 | MP0005220_abnormal_exocrine_pancreas | 0.71869402 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.71770887 |
| 119 | MP0003329_amyloid_beta_deposits | 0.71511312 |
| 120 | MP0009765_abnormal_xenobiotic_induced | 0.71302824 |
| 121 | MP0006035_abnormal_mitochondrial_morpho | 0.68764422 |
| 122 | MP0003690_abnormal_glial_cell | 0.68714549 |
| 123 | MP0000003_abnormal_adipose_tissue | 0.67880905 |
| 124 | MP0005408_hypopigmentation | 0.60061111 |
| 125 | MP0009115_abnormal_fat_cell | 0.57243599 |
| 126 | MP0003724_increased_susceptibility_to | 0.55329486 |
| 127 | MP0000639_abnormal_adrenal_gland | 0.54547703 |
| 128 | MP0003953_abnormal_hormone_level | 0.52498366 |
| 129 | MP0004782_abnormal_surfactant_physiolog | 0.51564041 |
| 130 | MP0002822_catalepsy | 0.50786105 |
| 131 | MP0005464_abnormal_platelet_physiology | 0.50503225 |
| 132 | MP0002136_abnormal_kidney_physiology | 0.49840703 |
| 133 | MP0002928_abnormal_bile_duct | 0.49308631 |
| 134 | MP0002970_abnormal_white_adipose | 0.48085231 |
| 135 | MP0000230_abnormal_systemic_arterial | 0.47990260 |
| 136 | MP0005395_other_phenotype | 0.43331980 |
| 137 | MP0008874_decreased_physiological_sensi | 0.42919891 |
| 138 | MP0003638_abnormal_response/metabolism_ | 0.42822925 |
| 139 | MP0003075_altered_response_to | 0.41555905 |
| 140 | MP0004185_abnormal_adipocyte_glucose | 0.41257345 |
| 141 | MP0005375_adipose_tissue_phenotype | 0.40001754 |
| 142 | MP0001881_abnormal_mammary_gland | 0.38166199 |
| 143 | MP0001853_heart_inflammation | 0.37287529 |
| 144 | MP0004043_abnormal_pH_regulation | 0.36875187 |
| 145 | MP0002168_other_aberrant_phenotype | 0.36179194 |
| 146 | MP0008872_abnormal_physiological_respon | 0.35851787 |
| 147 | MP0008873_increased_physiological_sensi | 0.35654487 |
| 148 | MP0005166_decreased_susceptibility_to | 0.34672455 |
| 149 | MP0003959_abnormal_lean_body | 0.34374184 |
| 150 | MP0002269_muscular_atrophy | 0.34055822 |
| 151 | MP0002090_abnormal_vision | 0.34037637 |
| 152 | MP0005058_abnormal_lysosome_morphology | 0.33207458 |
| 153 | MP0009672_abnormal_birth_weight | 0.32711831 |
| 154 | MP0000249_abnormal_blood_vessel | 0.32583935 |
| 155 | MP0009384_cardiac_valve_regurgitation | 0.31290959 |
| 156 | MP0003718_maternal_effect | 0.29033971 |
| 157 | MP0005330_cardiomyopathy | 0.28099309 |
| 158 | MP0005452_abnormal_adipose_tissue | 0.28042290 |
| 159 | MP0004147_increased_porphyrin_level | 0.27942460 |
| 160 | MP0001944_abnormal_pancreas_morphology | 0.27691308 |
| 161 | MP0004264_abnormal_extraembryonic_tissu | 0.27393675 |
| 162 | MP0005595_abnormal_vascular_smooth | 0.27348020 |
| 163 | MP0010234_abnormal_vibrissa_follicle | 0.26705429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.88569718 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.81148337 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.79388932 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.08687085 |
| 5 | Xanthomatosis (HP:0000991) | 6.07541794 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.97718237 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.90590135 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.38750851 |
| 9 | Complement deficiency (HP:0004431) | 5.23603372 |
| 10 | Hyperammonemia (HP:0001987) | 4.75782443 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.63999466 |
| 12 | Hyperglycinemia (HP:0002154) | 4.53171305 |
| 13 | Ketosis (HP:0001946) | 4.46579049 |
| 14 | Epidermoid cyst (HP:0200040) | 4.43642612 |
| 15 | Hyperglycinuria (HP:0003108) | 4.30746817 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.28822658 |
| 17 | Joint hemorrhage (HP:0005261) | 4.25660570 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.22590171 |
| 19 | Cutaneous melanoma (HP:0012056) | 4.19428431 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 4.19158151 |
| 21 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.19158151 |
| 22 | Hypoglycemic coma (HP:0001325) | 4.18879443 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 4.08017138 |
| 24 | Blue irides (HP:0000635) | 4.01903982 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.01444981 |
| 26 | Fat malabsorption (HP:0002630) | 3.99613321 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.99010328 |
| 28 | Hyperventilation (HP:0002883) | 3.97471175 |
| 29 | Abnormality of methionine metabolism (HP:0010901) | 3.88236929 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.87828307 |
| 31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.81157598 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.75814432 |
| 33 | Abnormality of complement system (HP:0005339) | 3.66867646 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.66496267 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.59032173 |
| 36 | Ketoacidosis (HP:0001993) | 3.50109466 |
| 37 | Hypercholesterolemia (HP:0003124) | 3.42626138 |
| 38 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.34127657 |
| 39 | Generalized hypopigmentation of hair (HP:0011358) | 3.24038099 |
| 40 | Hyperbilirubinemia (HP:0002904) | 3.22481260 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.18427847 |
| 42 | Fair hair (HP:0002286) | 3.16623500 |
| 43 | Delayed CNS myelination (HP:0002188) | 3.05306900 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 3.04743520 |
| 45 | Steatorrhea (HP:0002570) | 3.01265697 |
| 46 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.94085185 |
| 47 | Dicarboxylic aciduria (HP:0003215) | 2.94085185 |
| 48 | Metabolic acidosis (HP:0001942) | 2.91880081 |
| 49 | Skin nodule (HP:0200036) | 2.90349421 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.90051451 |
| 51 | Spontaneous abortion (HP:0005268) | 2.84729166 |
| 52 | Myocardial infarction (HP:0001658) | 2.84486200 |
| 53 | Hepatocellular carcinoma (HP:0001402) | 2.80163004 |
| 54 | Hypothermia (HP:0002045) | 2.77397730 |
| 55 | Thyroiditis (HP:0100646) | 2.76909314 |
| 56 | Lethargy (HP:0001254) | 2.74033840 |
| 57 | Abnormality of the renal cortex (HP:0011035) | 2.70922417 |
| 58 | Hemiparesis (HP:0001269) | 2.69328533 |
| 59 | Gaze-evoked nystagmus (HP:0000640) | 2.65921722 |
| 60 | Hypoglycemic seizures (HP:0002173) | 2.65064390 |
| 61 | Gout (HP:0001997) | 2.64967093 |
| 62 | Chronic hepatic failure (HP:0100626) | 2.58872715 |
| 63 | Hamartoma of the eye (HP:0010568) | 2.56837744 |
| 64 | Systemic lupus erythematosus (HP:0002725) | 2.56663206 |
| 65 | Large for gestational age (HP:0001520) | 2.55724356 |
| 66 | Abnormal gallbladder morphology (HP:0012437) | 2.53300496 |
| 67 | Hypochromic microcytic anemia (HP:0004840) | 2.50659185 |
| 68 | Cholelithiasis (HP:0001081) | 2.50339642 |
| 69 | Cerebral edema (HP:0002181) | 2.50112986 |
| 70 | Acanthocytosis (HP:0001927) | 2.48989999 |
| 71 | Sensorimotor neuropathy (HP:0007141) | 2.43622369 |
| 72 | Generalized aminoaciduria (HP:0002909) | 2.43149217 |
| 73 | Spastic diplegia (HP:0001264) | 2.40518253 |
| 74 | Calf muscle hypertrophy (HP:0008981) | 2.39988340 |
| 75 | Cholecystitis (HP:0001082) | 2.36500489 |
| 76 | Abnormal gallbladder physiology (HP:0012438) | 2.36500489 |
| 77 | Brushfield spots (HP:0001088) | 2.32271639 |
| 78 | Irritability (HP:0000737) | 2.31169438 |
| 79 | Neonatal onset (HP:0003623) | 2.30752498 |
| 80 | Macroorchidism (HP:0000053) | 2.27615280 |
| 81 | Congenital stationary night blindness (HP:0007642) | 2.26197468 |
| 82 | Mitral stenosis (HP:0001718) | 2.25868171 |
| 83 | Pancreatitis (HP:0001733) | 2.25201146 |
| 84 | Congenital sensorineural hearing impairment (HP:0008527) | 2.24207823 |
| 85 | Vascular calcification (HP:0004934) | 2.23604223 |
| 86 | Neoplasm of the adrenal cortex (HP:0100641) | 2.23168958 |
| 87 | Late onset (HP:0003584) | 2.20602252 |
| 88 | Progressive cerebellar ataxia (HP:0002073) | 2.19438116 |
| 89 | Vomiting (HP:0002013) | 2.17781692 |
| 90 | Pancreatic cysts (HP:0001737) | 2.17460843 |
| 91 | Renal cortical cysts (HP:0000803) | 2.15492668 |
| 92 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.13239570 |
| 93 | Esophageal varix (HP:0002040) | 2.11874274 |
| 94 | EEG with generalized epileptiform discharges (HP:0011198) | 2.10148134 |
| 95 | Malnutrition (HP:0004395) | 2.09283480 |
| 96 | Albinism (HP:0001022) | 2.08899380 |
| 97 | Epileptiform EEG discharges (HP:0011182) | 2.08349052 |
| 98 | Medial flaring of the eyebrow (HP:0010747) | 2.07959785 |
| 99 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.07570758 |
| 100 | Ocular albinism (HP:0001107) | 2.07545289 |
| 101 | Abnormality of the gallbladder (HP:0005264) | 2.07135614 |
| 102 | Generalized hypopigmentation (HP:0007513) | 2.05200379 |
| 103 | Glomerulonephritis (HP:0000099) | 2.04992915 |
| 104 | Cystic liver disease (HP:0006706) | 2.03857419 |
| 105 | Amyloidosis (HP:0011034) | 2.03832846 |
| 106 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.01555828 |
| 107 | Hydroxyprolinuria (HP:0003080) | 1.99838348 |
| 108 | Abnormality of proline metabolism (HP:0010907) | 1.99838348 |
| 109 | Hypsarrhythmia (HP:0002521) | 1.99446930 |
| 110 | Pancreatic fibrosis (HP:0100732) | 1.99274028 |
| 111 | Cardiovascular calcification (HP:0011915) | 1.99143820 |
| 112 | Abnormality of vitamin metabolism (HP:0100508) | 1.98864749 |
| 113 | Gingival bleeding (HP:0000225) | 1.97911057 |
| 114 | Enlarged kidneys (HP:0000105) | 1.96192423 |
| 115 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.96070194 |
| 116 | Hemorrhage of the eye (HP:0011885) | 1.95921666 |
| 117 | Hypoplasia of the fovea (HP:0007750) | 1.95295288 |
| 118 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.95295288 |
| 119 | Abnormal cartilage morphology (HP:0002763) | 1.95162959 |
| 120 | Elevated hepatic transaminases (HP:0002910) | 1.94398535 |
| 121 | Increased purine levels (HP:0004368) | 1.94024480 |
| 122 | Hyperuricemia (HP:0002149) | 1.94024480 |
| 123 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.93957872 |
| 124 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.93957872 |
| 125 | Hypertriglyceridemia (HP:0002155) | 1.93860686 |
| 126 | Hyperglycemia (HP:0003074) | 1.93736691 |
| 127 | Febrile seizures (HP:0002373) | 1.92766620 |
| 128 | Abnormality of the nasal septum (HP:0000419) | 1.92644837 |
| 129 | Bile duct proliferation (HP:0001408) | 1.92614990 |
| 130 | Abnormal biliary tract physiology (HP:0012439) | 1.92614990 |
| 131 | Thrombophlebitis (HP:0004418) | 1.92531318 |
| 132 | Neoplasm of the heart (HP:0100544) | 1.92307473 |
| 133 | Methylmalonic acidemia (HP:0002912) | 1.92162130 |
| 134 | Menorrhagia (HP:0000132) | 1.90689605 |
| 135 | Abnormality of the renal medulla (HP:0100957) | 1.89464864 |
| 136 | Lymphangioma (HP:0100764) | 1.88910618 |
| 137 | Opisthotonus (HP:0002179) | 1.88440624 |
| 138 | Nephronophthisis (HP:0000090) | 1.88355004 |
| 139 | Meningioma (HP:0002858) | 1.87265861 |
| 140 | Metaphyseal dysplasia (HP:0100255) | 1.86991900 |
| 141 | Proximal tubulopathy (HP:0000114) | 1.86807961 |
| 142 | Poikilocytosis (HP:0004447) | 1.85481242 |
| 143 | Type II lissencephaly (HP:0007260) | 1.85397402 |
| 144 | True hermaphroditism (HP:0010459) | 1.84754815 |
| 145 | Lip pit (HP:0100267) | 1.83110764 |
| 146 | Hematochezia (HP:0002573) | 1.81258744 |
| 147 | Widely spaced teeth (HP:0000687) | 1.80422403 |
| 148 | Abnormality of vitamin B metabolism (HP:0004340) | 1.78802639 |
| 149 | Acute hepatic failure (HP:0006554) | 1.78424725 |
| 150 | Myoglobinuria (HP:0002913) | 1.77777270 |
| 151 | Tubular atrophy (HP:0000092) | 1.76099926 |
| 152 | Nausea (HP:0002018) | 1.75642613 |
| 153 | Status epilepticus (HP:0002133) | 1.73794175 |
| 154 | Abnormal pancreas size (HP:0012094) | 1.73760041 |
| 155 | Patchy hypopigmentation of hair (HP:0011365) | 1.72606398 |
| 156 | Symptomatic seizures (HP:0011145) | 1.72595549 |
| 157 | Absent speech (HP:0001344) | 1.72499404 |
| 158 | Mucopolysacchariduria (HP:0008155) | 1.71822147 |
| 159 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.71822147 |
| 160 | White forelock (HP:0002211) | 1.71470541 |
| 161 | Testicular neoplasm (HP:0010788) | 1.71350548 |
| 162 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.70988030 |
| 163 | Abnormality of the fovea (HP:0000493) | 1.69715127 |
| 164 | Thyroid carcinoma (HP:0002890) | 1.67919362 |
| 165 | Iris hypopigmentation (HP:0007730) | 1.67714673 |
| 166 | Disproportionate short-trunk short stature (HP:0003521) | 1.67275902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.99596003 |
| 2 | SIK1 | 4.49482895 |
| 3 | FGFR4 | 4.13475547 |
| 4 | ERN1 | 3.88722696 |
| 5 | INSRR | 3.20778648 |
| 6 | TRIB3 | 2.84188308 |
| 7 | TAOK3 | 2.80347686 |
| 8 | BMPR1B | 2.50260309 |
| 9 | MAP4K2 | 2.32076669 |
| 10 | PKN2 | 2.26457128 |
| 11 | ERBB4 | 2.20302850 |
| 12 | MAP2K4 | 2.19018318 |
| 13 | STK39 | 2.13744375 |
| 14 | FLT3 | 1.88636731 |
| 15 | MAPK11 | 1.79638156 |
| 16 | FER | 1.75194769 |
| 17 | PIK3CG | 1.73114956 |
| 18 | TIE1 | 1.66040768 |
| 19 | PDK4 | 1.65863257 |
| 20 | PDK3 | 1.65863257 |
| 21 | FRK | 1.64756694 |
| 22 | ACVR1B | 1.63710127 |
| 23 | ERBB3 | 1.55258562 |
| 24 | CAMK1D | 1.55240853 |
| 25 | MST1R | 1.50250570 |
| 26 | TYK2 | 1.48167111 |
| 27 | NLK | 1.47706523 |
| 28 | NEK9 | 1.46080342 |
| 29 | DAPK2 | 1.43836010 |
| 30 | CAMKK2 | 1.38848985 |
| 31 | TRPM7 | 1.36693745 |
| 32 | MAP3K2 | 1.36580480 |
| 33 | CASK | 1.36384435 |
| 34 | PRKAA2 | 1.32752805 |
| 35 | NTRK3 | 1.29611792 |
| 36 | OBSCN | 1.29548379 |
| 37 | MAP3K7 | 1.28673872 |
| 38 | EIF2AK3 | 1.27434360 |
| 39 | PINK1 | 1.26807136 |
| 40 | PTK6 | 1.24676805 |
| 41 | KDR | 1.24432062 |
| 42 | BRSK2 | 1.23326431 |
| 43 | FGFR2 | 1.21204806 |
| 44 | MAPK13 | 1.19342892 |
| 45 | CSNK1A1L | 1.17041073 |
| 46 | JAK1 | 1.16236869 |
| 47 | MAP2K3 | 1.16020696 |
| 48 | WNK4 | 1.15265255 |
| 49 | JAK2 | 1.14336511 |
| 50 | LATS1 | 1.12157419 |
| 51 | WNK3 | 1.11845602 |
| 52 | MAPKAPK3 | 1.04403919 |
| 53 | OXSR1 | 0.98515015 |
| 54 | ADRBK2 | 0.97403166 |
| 55 | RIPK1 | 0.97054968 |
| 56 | PLK2 | 0.96242378 |
| 57 | ABL2 | 0.96068082 |
| 58 | TBK1 | 0.93420761 |
| 59 | PDK2 | 0.93382508 |
| 60 | PRKAA1 | 0.91391022 |
| 61 | TGFBR2 | 0.90635075 |
| 62 | SGK3 | 0.88289618 |
| 63 | CSNK1G3 | 0.87423993 |
| 64 | PRKCE | 0.86160752 |
| 65 | EPHA3 | 0.83464601 |
| 66 | MAPK12 | 0.83365821 |
| 67 | STK38L | 0.82980756 |
| 68 | CAMK1G | 0.82556393 |
| 69 | FGFR3 | 0.82099280 |
| 70 | CSNK1G2 | 0.81728450 |
| 71 | SGK2 | 0.80238329 |
| 72 | MAPK4 | 0.78053624 |
| 73 | LMTK2 | 0.77683608 |
| 74 | GRK6 | 0.74133642 |
| 75 | MARK1 | 0.71027919 |
| 76 | PRKACG | 0.69310041 |
| 77 | NUAK1 | 0.66399083 |
| 78 | MYLK | 0.65564611 |
| 79 | PTK2B | 0.65089993 |
| 80 | PDPK1 | 0.65031251 |
| 81 | MAP3K3 | 0.64995217 |
| 82 | WNK1 | 0.64828875 |
| 83 | RET | 0.64154273 |
| 84 | ERBB2 | 0.63304589 |
| 85 | PRKCZ | 0.62225307 |
| 86 | PIK3CA | 0.60582595 |
| 87 | MAP3K10 | 0.59934202 |
| 88 | IRAK3 | 0.59796772 |
| 89 | MAP3K4 | 0.59247175 |
| 90 | SGK494 | 0.57945719 |
| 91 | SGK223 | 0.57945719 |
| 92 | ADRBK1 | 0.57436584 |
| 93 | MAP3K6 | 0.57309203 |
| 94 | MAPK7 | 0.56887771 |
| 95 | MAP2K6 | 0.56695004 |
| 96 | PDK1 | 0.54706073 |
| 97 | MAP2K1 | 0.54583831 |
| 98 | STK24 | 0.54075617 |
| 99 | CAMK2G | 0.54040013 |
| 100 | IKBKE | 0.53791144 |
| 101 | CDK6 | 0.53756406 |
| 102 | STK3 | 0.52254054 |
| 103 | TEC | 0.51854189 |
| 104 | IGF1R | 0.51209261 |
| 105 | BCR | 0.51086301 |
| 106 | MET | 0.49015707 |
| 107 | MAP3K5 | 0.48588106 |
| 108 | MARK3 | 0.48148085 |
| 109 | BMPR2 | 0.48027568 |
| 110 | SGK1 | 0.47981357 |
| 111 | JAK3 | 0.47974911 |
| 112 | CSNK1D | 0.47831359 |
| 113 | IRAK1 | 0.46873689 |
| 114 | GSK3A | 0.46659672 |
| 115 | MAP3K14 | 0.45984981 |
| 116 | EEF2K | 0.45341671 |
| 117 | TNK2 | 0.45114716 |
| 118 | CSF1R | 0.44641928 |
| 119 | PRKCH | 0.44050326 |
| 120 | PAK6 | 0.41896954 |
| 121 | PTK2 | 0.41099139 |
| 122 | AKT3 | 0.40806090 |
| 123 | PRKCQ | 0.39901428 |
| 124 | TGFBR1 | 0.39742510 |
| 125 | PRKCG | 0.39586619 |
| 126 | CSK | 0.39186826 |
| 127 | ZAP70 | 0.39176676 |
| 128 | MAP3K11 | 0.39168208 |
| 129 | CCNB1 | 0.38740472 |
| 130 | MAP3K13 | 0.38538614 |
| 131 | STK11 | 0.38317649 |
| 132 | DYRK1B | 0.38245507 |
| 133 | MKNK2 | 0.37507277 |
| 134 | CSNK1A1 | 0.37417407 |
| 135 | NEK1 | 0.37397155 |
| 136 | MAP4K1 | 0.37124346 |
| 137 | PAK3 | 0.36841749 |
| 138 | PHKG2 | 0.36809320 |
| 139 | PHKG1 | 0.36809320 |
| 140 | PRKD3 | 0.36215812 |
| 141 | ITK | 0.36030184 |
| 142 | RPS6KB1 | 0.34790055 |
| 143 | HIPK2 | 0.34635171 |
| 144 | EPHB1 | 0.33337765 |
| 145 | TAOK2 | 0.32678615 |
| 146 | CHUK | 0.32631727 |
| 147 | CAMK2A | 0.32420613 |
| 148 | PRKACA | 0.31847423 |
| 149 | KIT | 0.30372192 |
| 150 | CAMK4 | 0.28169775 |
| 151 | CSNK1G1 | 0.27194933 |
| 152 | CAMKK1 | 0.26628742 |
| 153 | FGFR1 | 0.25958387 |
| 154 | GRK1 | 0.25276415 |
| 155 | STK38 | 0.24571780 |
| 156 | PDGFRA | 0.24551449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.31288442 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.43275521 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25949951 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.17759989 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.88765261 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.76836019 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.75089010 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.71179398 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67039105 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.66821385 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.52769637 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.38173781 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.37689060 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.29179126 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.16174838 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.11853345 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.09378077 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.09105921 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.97443549 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.85536993 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.83695290 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.80137435 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.79788998 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.75881793 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.74924404 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.73754758 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67755090 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.65166751 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.65022442 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63382714 |
| 31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.61802756 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.57484079 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52958008 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50866467 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.45941400 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.45253466 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.40187638 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38449088 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.36846799 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.34785771 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31908618 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31450729 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27894292 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.26896956 |
| 45 | Insulin secretion_Homo sapiens_hsa04911 | 1.20314968 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.19903848 |
| 47 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.17179781 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16437331 |
| 49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.14601083 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.06174274 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.05728858 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03803541 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94419771 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93452640 |
| 55 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.91579733 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90455009 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89216852 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86398061 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85250053 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84216951 |
| 61 | Renin secretion_Homo sapiens_hsa04924 | 0.83716517 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83605837 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82354325 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.81855354 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81226997 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.80358370 |
| 67 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.79151013 |
| 68 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.72704242 |
| 69 | Phototransduction_Homo sapiens_hsa04744 | 0.72456737 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70610634 |
| 71 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66805890 |
| 72 | Salivary secretion_Homo sapiens_hsa04970 | 0.65164301 |
| 73 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64198513 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62636684 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62179673 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60887375 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60392479 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58476575 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57879771 |
| 80 | Circadian entrainment_Homo sapiens_hsa04713 | 0.55528494 |
| 81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55500022 |
| 82 | Protein export_Homo sapiens_hsa03060 | 0.54923308 |
| 83 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51963002 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45638358 |
| 85 | Mineral absorption_Homo sapiens_hsa04978 | 0.44903938 |
| 86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.44867066 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44706040 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43960289 |
| 89 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41517829 |
| 90 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.40787540 |
| 91 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.39486978 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39325940 |
| 93 | Long-term depression_Homo sapiens_hsa04730 | 0.38759042 |
| 94 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.38311365 |
| 95 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.37633889 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.37026904 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35004905 |
| 98 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.34254854 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34243806 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32181097 |
| 101 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.29617659 |
| 102 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29209510 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.27930613 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24682656 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21389321 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20844558 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.17767456 |
| 108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.10431064 |
| 109 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.06120445 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.03786932 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.00398485 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | -0.2427525 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.2276275 |
| 114 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1983767 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1973821 |
| 116 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1961300 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1704208 |
| 118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1680438 |
| 119 | Hepatitis C_Homo sapiens_hsa05160 | -0.1672448 |
| 120 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1652007 |
| 121 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1621042 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1581444 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1252070 |
| 124 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1233499 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1093321 |
| 126 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1055224 |
| 127 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0982926 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0767231 |
| 129 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0688857 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0455977 |

